We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 19
Most popular |Most recent


2018 Highlights in Canadian Life Sciences IP

Canada - January 7 2019 In 2018 we reported on a number of developments in life sciences IP and regulatory law. Our most-read articles were: 1 a June update on biosimilars...


Certificate of Supplementary Protection Regime: First Anniversary Update

Canada - September 28 2018 September 21, 2018 marked the first anniversary of the certificate of supplementary protection (CSP) regime. CSPs, which provide an additional...

Daphne Lainson.


2018 Mid-Year Highlights in Canadian Life Sciences IP

USA, Canada - July 11 2018 Consultation on proposed Regulations Amending the Patented Medicines Regulations closed on February 15; consideration is ongoing. Potential changes to...


2017 Highlights in Canadian Life Sciences IP

Canada - January 10 2018 The year 2017 was one of the most significant years for Canadian Life Sciences IP and Regulatory Law in Canada’s history. The year saw major de...


Canada releases proposed amendments to Regulations governing patented medicines pricing

Canada - December 4 2017 On December 2, 2017 Canada’s Governor-in-Council published proposed Regulations Amending the Patented Medicines Regulations (“the proposed...

Daphne Lainson, Jeffrey Coles.